PMC:7172841 / 3971-4120 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T23","span":{"begin":34,"end":44},"obj":"Body_part"}],"attributes":[{"id":"A23","pred":"fma_id","subj":"T23","obj":"http://purl.org/sig/ont/fma/fma63261"}],"text":"e classified into three patterns: macrophage-activation syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by "}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T45","span":{"begin":34,"end":64},"obj":"Disease"},{"id":"T46","span":{"begin":66,"end":69},"obj":"Disease"}],"attributes":[{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"e classified into three patterns: macrophage-activation syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by "}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T30","span":{"begin":45,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"e classified into three patterns: macrophage-activation syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by "}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T19","span":{"begin":34,"end":55},"obj":"http://purl.obolibrary.org/obo/GO_0042116"}],"text":"e classified into three patterns: macrophage-activation syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by "}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T23","span":{"begin":101,"end":107},"obj":"Phenotype"}],"attributes":[{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0100806"}],"text":"e classified into three patterns: macrophage-activation syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by "}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T103","span":{"begin":34,"end":44},"obj":"CL:0000235;GO:0042116"},{"id":"T104","span":{"begin":44,"end":55},"obj":"GO:0042116"}],"text":"e classified into three patterns: macrophage-activation syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by "}

    2_test

    {"project":"2_test","denotations":[{"id":"32320677-28918754-19656930","span":{"begin":94,"end":98},"obj":"28918754"}],"text":"e classified into three patterns: macrophage-activation syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by "}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"198","span":{"begin":34,"end":64},"obj":"Disease"},{"id":"199","span":{"begin":101,"end":131},"obj":"Disease"}],"attributes":[{"id":"A198","pred":"tao:has_database_id","subj":"198","obj":"MESH:D055501"},{"id":"A199","pred":"tao:has_database_id","subj":"199","obj":"MESH:D018805"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e classified into three patterns: macrophage-activation syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by "}